Sudarshan Pharma strengthens leadership with two key appointments

Sudarshan Pharma Industries Limited has announced two significant appointments to its senior management, effective December 1, 2025. Rahul Pandey has been appointed as president – business operations & development (excipients & API division). Pandey brings over 15 years of experience in the global healthcare industry, focusing on growth, operational excellence, and portfolio diversification across various ingredients, with prior roles at Pfizer Limited and Mylan Limited.

Concurrently, Mayank Vyas has been appointed as president – business development manager. Vyas's career spans more than 20 years, with expertise in marketing and HR across sectors including construction equipment, tiles, pharma machinery, and chemicals. His experience also encompasses manufacturing quality competence, including leading product and process audits, and he has previously worked with organizations such as M/s. Dev Construction Equipment and M/s. Amin JCB.

These appointments follow the approval of the Nomination & Remuneration Committee and the Board of Directors.